Scientific Resources
Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.
Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.
Found 65 Results
March 9, 2023 | Presentation
Ultrasensitive Circulating Tumor DNA (ctDNA) Dynamics after Autologous CD30.CAR-T Cell Therapy for Relapsed or Refractory (r/r) Classical Hodgkin Lymphoma (CHARIOT Trial)
ASH
March 9, 2023 | Presentation
MRD-Negativity As a Potential Surrogate Endpoint after Frontline DLBCL Therapy: Pooled Analysis of Trials & Implications for Clinical Trial Design
ASH
November 15, 2022 | Presentation
Ultrasensitive MRD Profiling Predicts Outcomes in DLBCL after Frontline Therapy with Tafasitamab in Combination with Lenalidomide and R-CHOP
ASH
April 29, 2022 | Poster
Phase 2 Study of Acalabrutinib Window Prior to Frontline Therapy in Untreated Aggressive B-cell Lymphoma
ASH
April 1, 2022 | Manuscript
Inferring gene expression from cell-free DNA fragmentation profiles
Nature Biotechnology
March 29, 2022 | Article
Nature Biopharma Dealmakers: Closing the gap on minimal residual disease detection in cancer